September 6, 2022
Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the…
September 6, 2022
QIAGEN announces winners of 2022 Young Investigator Awards
The competition nurtures young scientists around the globe QIAGEN-Verogen generously donated a combined instrument and reagents prize package worth up…
September 6, 2022
Ampel BioSolutions Enters MDx Market With Lupus, Dermatology Gene Expression Assays | Genomeweb – 2
GENOME WEB, CHICAGO, IL, September 1, 2022 - - After nine years in business, precision medicine company AMPEL BioSolutions is…
September 6, 2022
Brett Shealy, Executive Director -Life Sciences Banking with J.P. Morgan, joins Rich Bendis on BioTalk
Brett Shealy, Executive Director of the Life Sciences Banking Team with J.P.Morgan, joins Rich Bendis on BioTalk to discuss his…
September 6, 2022
Brett Shealy, Executive Director -Life Sciences Banking with J.P. Morgan, joins Rich Bendis on BioTalk
Brett Shealy, Executive Director of the Life Sciences Banking Team with J.P.Morgan, joins Rich Bendis on BioTalk to discuss his…
September 2, 2022
White House to award $52.9 million grant to Va. Biotech authority
The Richmond region has won a $52.9 million federal grant to create a hub for research and advanced manufacturing of essential medicines…
September 2, 2022
Nvidia to build the U.K.’s fastest supercomputer for AI drug-hunters at GSK, AstraZeneca and more | Fierce Biotech
Through a new partnership with GlaxoSmithKline, AstraZeneca and the U.K.’s National Health Service, the chip maker Nvidia plans to build…
September 2, 2022
5 trends VCs, investors and founders are talking about right now | Silicon Valley Bank
Startup founders and investors are looking at what could be a murky investment outlook over the next few months or…
